FDA Approved: ZOLMITRIPTAN — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Zolmitriptan from Cipla USA Inc., granting continued authorization for the drug's use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Zolmitriptan (zolmitriptan)

Snippet

SUPPL AP for ZOLMITRIPTAN (ZOLMITRIPTAN)